Education
About Us
Working with TipRanks
Follow Us
ChitogenX (TSE:CHGX)
:CHGX
CHGX Stock Chart & Stats
C$0.01
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.01
C$0.00(0.00%)
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.04
Previous CloseN/A
Volume7.01K
Average Volume (3M)0.00
Market Cap
$415.65K
Enterprise ValueC$4.60M
Total Cash (Recent Filing)$48.00K
Total Debt (Recent Filing)$4.23M
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding83,129,520
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap11.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-255.65
Enterprise Value/Ebitda-3.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ChitogenX News
CHGX FAQ
What was ChitogenX’s price range in the past 12 months?
ChitogenX lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is ChitogenX’s market cap?
ChitogenX’s market cap is $415.65K.
When is ChitogenX’s upcoming earnings report date?
ChitogenX’s upcoming earnings report date is Sep 25, 2025 which is 26 days ago.
How were ChitogenX’s earnings last quarter?
Currently, no data Available
Is ChitogenX overvalued?
According to Wall Street analysts ChitogenX’s price is currently Overvalued.
Does ChitogenX pay dividends?
ChitogenX does not currently pay dividends.
What is ChitogenX’s EPS estimate?
ChitogenX’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ChitogenX have?
ChitogenX has 83,129,520 shares outstanding.
What happened to ChitogenX’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ChitogenX?
Currently, no hedge funds are holding shares in TSE:CHGX
Company Description
ChitogenX
ChitogenX (CHGX) is a biotechnology company specializing in regenerative medicine and advanced medical technologies. The company focuses on developing innovative solutions for tissue repair and healing, primarily leveraging its proprietary chitosan-based platform. ChitogenX is committed to improving patient outcomes through its cutting-edge products designed for a variety of medical applications, including orthopedics and wound care.
Technical Analysis
NanoSphere Health Sciences Inc
―
Biocure Technology Inc
―
Albert Labs International
―
Naturally Splendid
―
WPD Pharmaceuticals
―
Options Prices
Currently, No data available
---